Amgen (AMGN) Net Cash Flow (2009 - 2026)

Amgen has reported Net Cash Flow for 18 years, with the latest figure at $2.0 billion in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 349.49% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $6.0 billion, a 568.26% increase from a year earlier, with the FY2025 full-year figure at -$2.8 billion, down 376.38% from the prior year.
• Net Cash Flow was $2.0 billion for Q2 2026 at Amgen, down from $2.9 billion in the prior quarter.
• The five-year high for Net Cash Flow was $23.9 billion in Q1 2023, with the low at -$23.8 billion in Q4 2023.
• Average Net Cash Flow over 5 years is $333.3 million, with a median of -$303.0 million recorded in 2024.
• The largest YoY upside for Net Cash Flow was 1737.99% in 2023 against a maximum downside of 1170.53% in 2023.
• Over 5 years, Net Cash Flow stood at -$1.9 billion in 2022, then slumped by 1170.53% to -$23.8 billion in 2023, then soared by 112.45% to $3.0 billion in 2024, then slumped by 110.67% to -$316.0 million in 2025, then soared by 717.41% to $2.0 billion in 2026.
• The last three Net Cash Flow figures came in at $2.0 billion (Q2 2026), $2.9 billion (Q1 2026), and -$316.0 million (Q4 2025), per Business Quant data.